Publications by authors named "Jason M Lappe"

Claim this Profile
A
Ablation for Persistent Atrial Fibrillation-Is There a Role for More Than PVI?
Jason M Lappe, Michael J Cutler, John D Day, T Jared Bunch

Curr Treat Options Cardiovasc Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and prediction of obstructive coronary artery disease in patients referred for valvular heart surgery.
Jason M Lappé, Justin L Grodin, Yuping Wu, Corinne Bott-Silverman, Leslie Cho

Am J Cardiol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population.
Jason M Lappé, Benjamin D Horne, Svati H Shah, Heidi T May, Joseph B Muhlestein

Clin Chim Acta· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathy.
Jason M Lappé, Clara M Pelfrey, Anne Cotleur, Wai Hong Wilson Tang

Clin Transl Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiinflammatory autoimmune cellular responses to cardiac troponin I in idiopathic dilated cardiomyopathy.
Carmel M Halley, Jason M Lappé, Anne C Cotleur, Kevin Shrestha, Allen G Borowski

J Card Fail· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.
Jason M Lappé, Clara M Pelfrey, W H Wilson Tang

J Card Fail· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography.
Matthew T Rondina, Jason M Lappé, John F Carlquist, Joseph B Muhlestein, Matthew J Kolek

Cardiology· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease.
Troy E Madsen, Joseph B Muhlestein, John F Carlquist, Benjamin D Horne, Tami L Bair, Jason M Lappe

Am J Nephrol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program.
Jason M Lappé, Joseph B Muhlestein, Donald L Lappé, Rodney S Badger, Tami L Bair

Ann Intern Med· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization.
Jeffrey D Jackson, Joseph B Muhlestein, T Jared Bunch, Tami L Bair, Benjamin D Horne

Am Heart J· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis